High‐dose rate brachytherapy compared with open radical prostatectomy for the treatment of high‐risk prostate cancer: 10 year biochemical freedom from relapse
Open Access
- 29 November 2012
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 110 (S4) , 71-76
Abstract
Objective To compare long‐term biochemical control of high‐risk prostate cancer in those men receiving high‐dose rate brachytherapy (HDRB) and radical prostatectomy (RP). Patients and methods The 10‐year biochemical freedom from relapse (BFR) was calculated for 243 patients who underwent either RP or combined therapy with HDRB + external beam radiotherapy + androgen deprivation between 1998 and 2000. Inclusion criteria: clinical stage ≥ T2b, or Gleason sum ≥ 8, or PSA level of > 20 ng/mL. Groups were appraised using the Kattan nomogram for surgery to calculate progression‐free probability (PFP). Results For the RP group (153 patients) the median PSA level was 8.1 ng/mL and the median age was 62.2 years. The median 5‐ and 10‐year predicted PFP for RP was 64% and 56 %, respectively. The 5‐ and 10‐year BFR was 65.5% and 55.4%. There was no significant difference between the predicted and the actual PFP for the RP group ( P = 0.525). For HDRB group (90 patients). The median PSA level was 14.2 ng/mL and the median age was 67.6 years. The median 5‐ and 10‐year predicted PFP for HDRB was 46% and 35%, respectively. The 5‐ and 10‐year BFR was 79.6% and 53.6%. There was a significant improvement between the actual and the predicted PFP for the HDRB group ( P = 0.002). Conclusions Amongst a high‐risk cohort, patients undergoing RP performed as predicted by the pre‐treatment surgical nomogram, whereas the patients undergoing HDRB performed significantly better than was predicted by the surgical nomogram at 10 years.Keywords
This publication has 25 references indexed in Scilit:
- Radical Prostatectomy in High-Grade Prostate Cancer, Salvage and Adjuvant RadiotherapyUrologia Internationalis, 2010
- Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRTBrachytherapy, 2010
- Stage migration in localized prostate cancer has no effect on the post‐radical prostatectomy Kattan nomogramBJU International, 2010
- Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical ProstatectomyJournal of Urology, 2009
- Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen EraJournal of Clinical Oncology, 2009
- Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative StudiesEuropean Urology, 2009
- Adjuvant Radiotherapy for Pathologically Advanced Prostate CancerJAMA, 2006
- Treatment of localized prostate cancer using a combination of high dose rate Iridium‐192 brachytherapy and external beam irradiation: Initial Australian experienceAustralasian Radiology, 2003
- Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate CancerJournal of Clinical Oncology, 2002
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998